Sera Prognostics Increases Series B Financing to $25M With New Investor
February 4, 2015Sera Prognostics receives funding from the Bill & Melinda Gates Foundation that increases their Series B financing to $25 million. The additional funding will help in the development of new proteomic tests to predict preterm birth for women in developing
More »
Marinus Pharmaceuticals Initiates Clinical Trial With Ganaxolone in PCDH19 Female Pediatric Epilepsy
February 3, 2015Marinus Pharmaceuticals initiates a Phase 2 clinical trial to evaluate ganaxolone for the treatment of PCDH19 female pediatric epilepsy, a rare disease caused by mutation in gene PCDH19, which currently has no approved therapies.
More »
Esperion Therapeutics Announces Removal of PPAR Partial Clinical Hold for ETC-1002
February 2, 2015Esperion Therapeutics announces the FDA removed the PPAR partial clinical hold on ETC-1002, their lead product candidate in late-stage clinical evaluation, now allowing clinical trials exceeding 6 months.
More »